Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 08 Dec 2015
At a glance
- Drugs Pidilizumab (Primary) ; Dendritic cell vaccines
- Indications Multiple myeloma
- Focus Pharmacodynamics
- 08 Dec 2015 Results (n=22) presented at the 57th Annual Meeting and Exposition of the American Society of Hematology.
- 22 Nov 2013 Planned end date changed from 1 Mar 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 25 Jun 2013 Planned end date changed from 1 Mar 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov.